Lorenza Rimassa

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 353 publications

From the Editor's Desk...

From the Editor's Desk...

Journal: Journal of hepatology

Published: August 19, 2026

The EvIDHence study: real-world treatment patterns and safety outcomes in mutant and wild-type IDH1 cholangiocarcinoma before availability of mIDH1 inhibitors.

The EvIDHence study: real-world treatment patterns and safety outcomes in mutant and wild-type IDH1 cholangiocarcinoma before availability of mIDH1 inhibitors.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

From the Editor's Desk...

From the Editor's Desk...

Journal: Journal of hepatology

Published: July 15, 2026

The hepatocellular carcinoma wish list: Five aspirations for future care.

The hepatocellular carcinoma wish list: Five aspirations for future care.

Journal: Journal of hepatology

Published: June 25, 2026

From the Editor's Desk….

From the Editor's Desk….

Journal: Journal of hepatology

Published: June 15, 2026

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 03, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 01, 2026

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

Journal: ESMO gastrointestinal oncology

Published: May 22, 2026

Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer).

Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer).

Journal: Future oncology (London, England)

Published: May 11, 2026

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

Journal: Nature reviews. Clinical oncology

Published: May 06, 2026

Reply to: "Establish a streamlined molecular profiling workflow for the clinical management of advanced cholangiocarcinoma".

Reply to: "Establish a streamlined molecular profiling workflow for the clinical management of advanced cholangiocarcinoma".

Journal: Journal of hepatology

Published: May 05, 2026

Showing 1-12 of 353

Last Updated: 09/26/2026